Nicolas Leduc
Impact in
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
-
- COVID-19 and healthcare impacts
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Prostate Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 2
-
- Advanced Radiotherapy Techniques 3
- Co-authors
- Vincent Vinh‐Hung (11 shared papers)Paul Sargos (7 shared papers)Patrick Escarmant (5 shared papers)Adeline Petit (1 shared paper)Kohei Okita (2 shared papers)Kazuyasu Sugiyama (2 shared papers)Shu Takagi (2 shared papers)Yoichiro Matsumoto (2 shared papers)
- Journals
- Brachytherapy (3 papers)Frontiers in Oncology (2 papers)Globalization and Health (1 paper)Applied Sciences (1 paper)Medical dosimetry (1 paper)
- Partner nations
- FranceMartiniqueUnited States
In The Last Decade
Nicolas Leduc
24 papers receiving 512 citations
Nicolas Leduc's Hit Papers
Peers
Comparison fields: 5 of 52
- Cancer Research 149
- Oncology 206
- Pulmonary and Respiratory Medicine 183
- Radiology, Nuclear Medicine and Imaging 51
- Infectious Diseases 42
Countries citing papers authored by Nicolas Leduc
This map shows the geographic impact of Nicolas Leduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Leduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Leduc more than expected).
Fields of papers citing papers by Nicolas Leduc
This network shows the impact of papers produced by Nicolas Leduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Leduc. The network helps show where Nicolas Leduc may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Leduc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2022 | 248 |
| 2 | 2020 | 124 | |
| 3 | 2018 | 28 | |
| 4 | 2012 | 13 | |
| 5 | 2017 | 13 | |
| 6 | 2021 | 11 | |
| 7 | 2016 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2016 | 9 | |
| 10 | 2019 | 6 | |
| 11 | 2017 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2015 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2017 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2019 | 2 |
About Nicolas Leduc
Nicolas Leduc is a scholar working on Pulmonary and Respiratory Medicine, Radiation, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 25 papers that have together received 517 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (5 papers), Advanced Radiotherapy Techniques (3 papers), Breast Cancer Treatment Studies (2 papers), Microwave Imaging and Scattering Analysis (2 papers), Ultrasonics and Acoustic Wave Propagation (2 papers), Lung Cancer Treatments and Mutations (2 papers), COVID-19 and healthcare impacts (2 papers) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Cancer Research (149 citations), Oncology (206 citations), Pulmonary and Respiratory Medicine (183 citations), Radiology, Nuclear Medicine and Imaging (51 citations) and Infectious Diseases (42 citations). Nicolas Leduc has collaborated with scholars based in France, Martinique and United States. Frequent co-authors include Vincent Vinh‐Hung, Paul Sargos, Patrick Escarmant, Adeline Petit, Kohei Okita, Kazuyasu Sugiyama, Shu Takagi, Yoichiro Matsumoto, Vincent Molinié and Nam Phong Nguyen. Their work appears in journals such as Brachytherapy, Frontiers in Oncology, Globalization and Health, Applied Sciences and Medical dosimetry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.